[{"Assets_0_Q3_USD":659045000.0,"CommonStockSharesOutstanding_0_Q3_shares":41061181.0,"NetIncomeLoss_1_Q3_USD":-640000.0,"NetIncomeLoss_3_Q3_USD":-8756000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":82708000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":237713000.0,"StockholdersEquity_0_Q3_USD":301266000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":40995000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":40833000.0,"Ticker":"PCRX","CIK":"1396814","name":"PACIRA PHARMACEUTICALS, INC.","OfficialName":"Pacira BioSciences Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3316489486.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181101"}]